Both groups are at increased risk of Alzheimer’s disease, although the low levels of amyloid and tau pathology detected on PET indicates that conversion to Alzheimer’s disease was not likely imminent in most of the participants. This evidence concerns the gene MAPT and early-onset autosomal dominant Alzheimer disease.